Live from the NIH registry
Studies recruiting near Lancaster right now
Top 25 of 427 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Lancaster General Hospital — Lancaster, Pennsylvania (0.4 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Penn State Health — Hershey, Pennsylvania (25.0 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Cancer Care Associates Of York /ID# 266143 — York, Pennsylvania (23.2 mi)
· Sponsor: AbbVie
Ultrasound Guided Serratus Anterior Plane Block for Rib Fractures
Rib Fracture Multiple
N/A
Interventional 60 participants sought
Wellspan Health York Hospital — York, Pennsylvania (23.2 mi)
· Sponsor: WellSpan Health
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Lancaster, Pennsylvania (0.4 mi)
· Sponsor: AstraZeneca
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Giselle Sholler
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Wyomissing, Pennsylvania (26.6 mi)
· Sponsor: Alkermes, Inc.
A Study of MZE782 in Adults With PKU
Phenylketonuria (PKU)
Phase 2
Interventional 38 participants sought
Clinic for Special Children — Gordonville, Pennsylvania (9.0 mi)
· Sponsor: Maze Therapeutics
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Cancer Care Associates of York (site 206) — York, Pennsylvania (23.2 mi)
· Sponsor: VM Oncology, LLC
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Reading Hospital — West Reading, Pennsylvania (27.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Lancaster, Pennsylvania (0.4 mi)
· Sponsor: Alnylam Pharmaceuticals
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Lancaster General Hospital - Ann B Barshinger Cancer Institute — Lancaster, Pennsylvania (0.4 mi)
· Sponsor: Eli Lilly and Company
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Penn State Milton S Hershey Medical Ctr — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Janssen Research & Development, LLC
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Penn State Children's Hospital — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Children's Oncology Group
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
NSCLC, Stage I
Phase 2
Interventional 244 participants sought
Penn State Cancer Institute — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Greg Durm, MD
FORWARD CAD IDE Study
Coronary Arterial Disease (CAD)
N/A
Interventional 408 participants sought
Wellspan York Hospital — York, Pennsylvania (23.2 mi)
· Sponsor: Shockwave Medical, Inc.
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Osteosarcoma, Ewing Sarcoma
Phase 2
Interventional 406 participants sought
Penn State Milton S. Hershey Medical Center and Children's Hospital — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Milton S. Hershey Medical Center
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Atherosclerosis, Cardiovascular Diseases
Phase 3
Interventional 252 participants sought
Heart and Vascular Research at WellSpan Health — York, Pennsylvania (23.2 mi)
· Sponsor: Eli Lilly and Company
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
Cholecystitis, Acute, Biliary Diseases
N/A
Interventional 90 participants sought
WellSpan Health York Hospital — York, Pennsylvania (23.2 mi)
· Sponsor: WellSpan Health
Reduction of Adverse Drug Events and Readmissions
Pharmacogenomic Testing for Medication Management
N/A
Observational 280,000 participants sought
MD@Home — York, Pennsylvania (23.2 mi)
· Sponsor: ClinLogic LLC
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Ephrata Cancer Center — Ephrata, Pennsylvania (11.5 mi)
· Sponsor: SWOG Cancer Research Network
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Penn State Hershey — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Novartis Pharmaceuticals
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Endometrial Cancer
N/A
Interventional 350 participants sought
Wellspan Health — York, Pennsylvania (23.2 mi)
· Sponsor: WellSpan Health
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Steba Biotech S.A.
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania (25.0 mi)
· Sponsor: Regeneron Pharmaceuticals